271 related articles for article (PubMed ID: 11880585)
21. An innovative approach to the determination of safety for a dietary ingredient derived from a new source: case study using a crystalline lutein product.
Kruger CL; Murphy M; DeFreitas Z; Pfannkuch F; Heimbach J
Food Chem Toxicol; 2002 Nov; 40(11):1535-49. PubMed ID: 12176081
[TBL] [Abstract][Full Text] [Related]
22. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer.
Khachik F; Beecher GR; Smith JC
J Cell Biochem Suppl; 1995; 22():236-46. PubMed ID: 8538204
[TBL] [Abstract][Full Text] [Related]
23. Effects of lutein and zeaxanthin on aspects of eye health.
Ma L; Lin XM
J Sci Food Agric; 2010 Jan; 90(1):2-12. PubMed ID: 20355006
[TBL] [Abstract][Full Text] [Related]
24. Thermal processing of vegetables increases cis isomers of lutein and zeaxanthin.
Updike AA; Schwartz SJ
J Agric Food Chem; 2003 Oct; 51(21):6184-90. PubMed ID: 14518942
[TBL] [Abstract][Full Text] [Related]
25. Variation in Carotenoid Content of Kale and Other Vegetables: A Review of Pre- and Post-harvest Effects.
Walsh RP; Bartlett H; Eperjesi F
J Agric Food Chem; 2015 Nov; 63(44):9677-82. PubMed ID: 26477753
[TBL] [Abstract][Full Text] [Related]
26. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative.
Moeller SM; Parekh N; Tinker L; Ritenbaugh C; Blodi B; Wallace RB; Mares JA;
Arch Ophthalmol; 2006 Aug; 124(8):1151-62. PubMed ID: 16908818
[TBL] [Abstract][Full Text] [Related]
27. Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health.
Abdel-Aal el-SM; Akhtar H; Zaheer K; Ali R
Nutrients; 2013 Apr; 5(4):1169-85. PubMed ID: 23571649
[TBL] [Abstract][Full Text] [Related]
28. Lutein and zeaxanthin status and risk of age-related macular degeneration.
Gale CR; Hall NF; Phillips DI; Martyn CN
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2461-5. PubMed ID: 12766044
[TBL] [Abstract][Full Text] [Related]
29. Nutrition and the aging retina: A comprehensive review of the relationship between nutrients and their role in age-related macular degeneration and retina disease prevention.
Walchuk C; Suh M
Adv Food Nutr Res; 2020; 93():293-332. PubMed ID: 32711865
[TBL] [Abstract][Full Text] [Related]
30. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina.
Rapp LM; Maple SS; Choi JH
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1200-9. PubMed ID: 10752961
[TBL] [Abstract][Full Text] [Related]
31. Age-related macular degeneration and its possible prevention.
Cohen MM
Med J Aust; 2005 Mar; 182(6):310-1; author reply 311. PubMed ID: 15777153
[No Abstract] [Full Text] [Related]
32. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas.
Khachik F; Bernstein PS; Garland DL
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1802-11. PubMed ID: 9286269
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS).
Dasch B; Fuhs A; Schmidt J; Behrens T; Meister A; Wellmann J; Fobker M; Pauleikhoff D; Hense HW
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1028-35. PubMed ID: 15909159
[TBL] [Abstract][Full Text] [Related]
34. Why is Zeaxanthin the Most Concentrated Xanthophyll in the Central Fovea?
Widomska J; SanGiovanni JP; Subczynski WK
Nutrients; 2020 May; 12(5):. PubMed ID: 32392888
[TBL] [Abstract][Full Text] [Related]
35. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin.
Broekmans WM; Berendschot TT; Klöpping-Ketelaars IA; de Vries AJ; Goldbohm RA; Tijburg LB; Kardinaal AF; van Poppel G
Am J Clin Nutr; 2002 Sep; 76(3):595-603. PubMed ID: 12198005
[TBL] [Abstract][Full Text] [Related]
36. Carotenoid intakes, assessed by dietary questionnaire, are associated with plasma carotenoid concentrations in an elderly population.
Tucker KL; Chen H; Vogel S; Wilson PW; Schaefer EJ; Lammi-Keefe CJ
J Nutr; 1999 Feb; 129(2):438-45. PubMed ID: 10024624
[TBL] [Abstract][Full Text] [Related]
37. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.
; Chew EY; SanGiovanni JP; Ferris FL; Wong WT; Agron E; Clemons TE; Sperduto R; Danis R; Chandra SR; Blodi BA; Domalpally A; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Friberg TR; Rosenfeld PJ; Toth CA; Bernstein P
JAMA Ophthalmol; 2013 Jul; 131(7):843-50. PubMed ID: 23645227
[TBL] [Abstract][Full Text] [Related]
38. Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.
Wu J; Cho E; Willett WC; Sastry SM; Schaumberg DA
JAMA Ophthalmol; 2015 Dec; 133(12):1415-24. PubMed ID: 26447482
[TBL] [Abstract][Full Text] [Related]
39. Distribution of macular pigment components, zeaxanthin and lutein, in human retina.
Bone RA; Landrum JT
Methods Enzymol; 1992; 213():360-6. PubMed ID: 1435311
[No Abstract] [Full Text] [Related]
40. The role of lutein in eye-related disease.
Koushan K; Rusovici R; Li W; Ferguson LR; Chalam KV
Nutrients; 2013 May; 5(5):1823-39. PubMed ID: 23698168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
